Report Detail

Other Global Endoscope + Radiofrequency Ablation (RFA) Market Size, Status and Forecast 2019-2025

  • RnM2683435
  • |
  • 11 July, 2019
  • |
  • Global
  • |
  • 95 Pages
  • |
  • QYResearch
  • |
  • Other

Radiofrequency ablation (RFA) is one of the most promising ablative techniques for BE. The technique uses a bipolar electrode that is available as a balloon-based device for primary circumferential ablation or as a cap-based device that can be mounted on the tip of the endoscope for focal ablation.
The key factors that boost the growth of the global endoscope + radiofrequency ablation (RFA) market include upsurge in demand for novel treatment methods for patients suffering from cancer, cardiovascular diseases, and disorders associated with chronic pain along with the benefits offered by this advanced treatment modality. Several research studies have concluded that radiofrequency ablation (RFA) treatment efficiently creates lesion in the targeted body parts while maintaining short procedure durations.
In 2018, the global Endoscope + Radiofrequency Ablation (RFA) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Endoscope + Radiofrequency Ablation (RFA) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Endoscope + Radiofrequency Ablation (RFA) development in United States, Europe and China.

The key players covered in this study
Boston Scientific Corporation Conmed Corporation
Medtronic Plc (Covidien Plc)
Smith & Nephew Plc
Stryker Corporation
Halyard Health
Abbott Laboratories (St. Jude Medical, Inc.)
AngioDynamics
Hologic
AtriCure

Market segment by Type, the product can be split into
Focal Ablation
Others

Market segment by Application, split into
Cardiology Application
Pain Management
Oncology Application
Other Application

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Endoscope + Radiofrequency Ablation (RFA) status, future forecast, growth opportunity, key market and key players.
To present the Endoscope + Radiofrequency Ablation (RFA) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Endoscope + Radiofrequency Ablation (RFA) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Endoscope + Radiofrequency Ablation (RFA) Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Focal Ablation
      • 1.4.3 Others
    • 1.5 Market by Application
      • 1.5.1 Global Endoscope + Radiofrequency Ablation (RFA) Market Share by Application (2014-2025)
      • 1.5.2 Cardiology Application
      • 1.5.3 Pain Management
      • 1.5.4 Oncology Application
      • 1.5.5 Other Application
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Endoscope + Radiofrequency Ablation (RFA) Market Size
    • 2.2 Endoscope + Radiofrequency Ablation (RFA) Growth Trends by Regions
      • 2.2.1 Endoscope + Radiofrequency Ablation (RFA) Market Size by Regions (2014-2025)
      • 2.2.2 Endoscope + Radiofrequency Ablation (RFA) Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Endoscope + Radiofrequency Ablation (RFA) Market Size by Manufacturers
      • 3.1.1 Global Endoscope + Radiofrequency Ablation (RFA) Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Endoscope + Radiofrequency Ablation (RFA) Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Endoscope + Radiofrequency Ablation (RFA) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Endoscope + Radiofrequency Ablation (RFA) Key Players Head office and Area Served
    • 3.3 Key Players Endoscope + Radiofrequency Ablation (RFA) Product/Solution/Service
    • 3.4 Date of Enter into Endoscope + Radiofrequency Ablation (RFA) Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Endoscope + Radiofrequency Ablation (RFA) Market Size by Type (2014-2019)
    • 4.2 Global Endoscope + Radiofrequency Ablation (RFA) Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Endoscope + Radiofrequency Ablation (RFA) Market Size (2014-2019)
    • 5.2 Endoscope + Radiofrequency Ablation (RFA) Key Players in United States
    • 5.3 United States Endoscope + Radiofrequency Ablation (RFA) Market Size by Type
    • 5.4 United States Endoscope + Radiofrequency Ablation (RFA) Market Size by Application

    6 Europe

    • 6.1 Europe Endoscope + Radiofrequency Ablation (RFA) Market Size (2014-2019)
    • 6.2 Endoscope + Radiofrequency Ablation (RFA) Key Players in Europe
    • 6.3 Europe Endoscope + Radiofrequency Ablation (RFA) Market Size by Type
    • 6.4 Europe Endoscope + Radiofrequency Ablation (RFA) Market Size by Application

    7 China

    • 7.1 China Endoscope + Radiofrequency Ablation (RFA) Market Size (2014-2019)
    • 7.2 Endoscope + Radiofrequency Ablation (RFA) Key Players in China
    • 7.3 China Endoscope + Radiofrequency Ablation (RFA) Market Size by Type
    • 7.4 China Endoscope + Radiofrequency Ablation (RFA) Market Size by Application

    8 Japan

    • 8.1 Japan Endoscope + Radiofrequency Ablation (RFA) Market Size (2014-2019)
    • 8.2 Endoscope + Radiofrequency Ablation (RFA) Key Players in Japan
    • 8.3 Japan Endoscope + Radiofrequency Ablation (RFA) Market Size by Type
    • 8.4 Japan Endoscope + Radiofrequency Ablation (RFA) Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Endoscope + Radiofrequency Ablation (RFA) Market Size (2014-2019)
    • 9.2 Endoscope + Radiofrequency Ablation (RFA) Key Players in Southeast Asia
    • 9.3 Southeast Asia Endoscope + Radiofrequency Ablation (RFA) Market Size by Type
    • 9.4 Southeast Asia Endoscope + Radiofrequency Ablation (RFA) Market Size by Application

    10 India

    • 10.1 India Endoscope + Radiofrequency Ablation (RFA) Market Size (2014-2019)
    • 10.2 Endoscope + Radiofrequency Ablation (RFA) Key Players in India
    • 10.3 India Endoscope + Radiofrequency Ablation (RFA) Market Size by Type
    • 10.4 India Endoscope + Radiofrequency Ablation (RFA) Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Endoscope + Radiofrequency Ablation (RFA) Market Size (2014-2019)
    • 11.2 Endoscope + Radiofrequency Ablation (RFA) Key Players in Central & South America
    • 11.3 Central & South America Endoscope + Radiofrequency Ablation (RFA) Market Size by Type
    • 11.4 Central & South America Endoscope + Radiofrequency Ablation (RFA) Market Size by Application

    12 International Players Profiles

    • 12.1 Boston Scientific Corporation Conmed Corporation
      • 12.1.1 Boston Scientific Corporation Conmed Corporation Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Endoscope + Radiofrequency Ablation (RFA) Introduction
      • 12.1.4 Boston Scientific Corporation Conmed Corporation Revenue in Endoscope + Radiofrequency Ablation (RFA) Business (2014-2019)
      • 12.1.5 Boston Scientific Corporation Conmed Corporation Recent Development
    • 12.2 Medtronic Plc (Covidien Plc)
      • 12.2.1 Medtronic Plc (Covidien Plc) Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Endoscope + Radiofrequency Ablation (RFA) Introduction
      • 12.2.4 Medtronic Plc (Covidien Plc) Revenue in Endoscope + Radiofrequency Ablation (RFA) Business (2014-2019)
      • 12.2.5 Medtronic Plc (Covidien Plc) Recent Development
    • 12.3 Smith & Nephew Plc
      • 12.3.1 Smith & Nephew Plc Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Endoscope + Radiofrequency Ablation (RFA) Introduction
      • 12.3.4 Smith & Nephew Plc Revenue in Endoscope + Radiofrequency Ablation (RFA) Business (2014-2019)
      • 12.3.5 Smith & Nephew Plc Recent Development
    • 12.4 Stryker Corporation
      • 12.4.1 Stryker Corporation Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Endoscope + Radiofrequency Ablation (RFA) Introduction
      • 12.4.4 Stryker Corporation Revenue in Endoscope + Radiofrequency Ablation (RFA) Business (2014-2019)
      • 12.4.5 Stryker Corporation Recent Development
    • 12.5 Halyard Health
      • 12.5.1 Halyard Health Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Endoscope + Radiofrequency Ablation (RFA) Introduction
      • 12.5.4 Halyard Health Revenue in Endoscope + Radiofrequency Ablation (RFA) Business (2014-2019)
      • 12.5.5 Halyard Health Recent Development
    • 12.6 Abbott Laboratories (St. Jude Medical, Inc.)
      • 12.6.1 Abbott Laboratories (St. Jude Medical, Inc.) Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Endoscope + Radiofrequency Ablation (RFA) Introduction
      • 12.6.4 Abbott Laboratories (St. Jude Medical, Inc.) Revenue in Endoscope + Radiofrequency Ablation (RFA) Business (2014-2019)
      • 12.6.5 Abbott Laboratories (St. Jude Medical, Inc.) Recent Development
    • 12.7 AngioDynamics
      • 12.7.1 AngioDynamics Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Endoscope + Radiofrequency Ablation (RFA) Introduction
      • 12.7.4 AngioDynamics Revenue in Endoscope + Radiofrequency Ablation (RFA) Business (2014-2019)
      • 12.7.5 AngioDynamics Recent Development
    • 12.8 Hologic
      • 12.8.1 Hologic Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Endoscope + Radiofrequency Ablation (RFA) Introduction
      • 12.8.4 Hologic Revenue in Endoscope + Radiofrequency Ablation (RFA) Business (2014-2019)
      • 12.8.5 Hologic Recent Development
    • 12.9 AtriCure
      • 12.9.1 AtriCure Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Endoscope + Radiofrequency Ablation (RFA) Introduction
      • 12.9.4 AtriCure Revenue in Endoscope + Radiofrequency Ablation (RFA) Business (2014-2019)
      • 12.9.5 AtriCure Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Endoscope + Radiofrequency Ablation (RFA) . Industry analysis & Market Report on Endoscope + Radiofrequency Ablation (RFA) is a syndicated market report, published as Global Endoscope + Radiofrequency Ablation (RFA) Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Endoscope + Radiofrequency Ablation (RFA) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,131.70
      4,697.55
      6,263.40
      3,666.00
      5,499.00
      7,332.00
      600,912.00
      901,368.00
      1,201,824.00
      325,689.00
      488,533.50
      651,378.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report